{"nct_id":"NCT03462719","title":"A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2018-04-17","start_date_type":"ACTUAL","primary_completion_date":"2021-02-26","primary_completion_date_type":"ACTUAL","completion_date":"2029-04-05","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JNJ"]}